Four of these five patients—two with cervical cancer, one with breast cancer, and one with germline cancer—had at least two molecular alterations involving the PI3K/AKT/mTOR pathway, including STK11 and INPP4B (Table 2). Here, AKT1 is linked to cervical cancer.